CTCX Insider Trading
Insider Ownership Percentage: 29.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Carmell Share Price & Price History
Current Price: $0.54
Price Change: ▲ Price Increase of +0.0173 (3.32%)
As of 11/28/2025 01:00 AM ET
Carmell Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 9/10/2024 | Bryan J Cassaday | CFO | Buy | 475 | $0.46 | $218.50 | 4,250 |  |
| 9/6/2024 | Kathryn Gregory | Director | Buy | 1,260 | $0.51 | $642.60 | 22,500 | |
| 8/30/2024 | Scott M Frisch | Director | Buy | 87 | $0.57 | $49.59 | 6,589 | |
| 8/29/2024 | Bryan J Cassaday | CFO | Buy | 1,000 | $0.57 | $570.00 | 3,775 | |
| 8/28/2024 | Patrick A Sturgeon | Director | Buy | 970 | $0.56 | $543.20 | 16,029 | |
| 8/26/2024 | Patrick A Sturgeon | Director | Buy | 1,587 | $0.72 | $1,142.64 | 13,472 | |
| 8/22/2024 | Kathryn Gregory | Director | Buy | 2,413 | $0.72 | $1,737.36 | 12,156 | |
| 8/20/2024 | Richard A Upton | Director | Buy | 3,600 | $0.89 | $3,204.00 | 10,000 | |
| 6/12/2024 | Richard A Upton | Director | Buy | 2,000 | $2.20 | $4,400.00 | 6,400 | |
| 6/10/2024 | Bryan J Cassaday | CFO | Buy | 440 | $2.50 | $1,100.00 | 2,775 | |
| 6/6/2024 | Rajiv Shukla | CEO | Buy | 2,100 | $2.63 | $5,523.00 | 72,103 | |
| 5/30/2024 | Rajiv Shukla | CEO | Buy | 2,000 | $2.50 | $5,000.00 | 70,003 | |
| 5/29/2024 | Bryan J Cassaday | CFO | Buy | 30 | $2.60 | $78.00 | 1,970 | |
| 5/28/2024 | Rajiv Shukla | CEO | Buy | 20 | $2.57 | $51.40 | 68,003 | |
| 5/24/2024 | Rajiv Shukla | CEO | Buy | 1,939 | $2.57 | $4,983.23 | 67,983 | |
| 5/22/2024 | Rajiv Shukla | CEO | Buy | 4,051 | $2.41 | $9,762.91 | 63,944 | |
| 5/20/2024 | Rajiv Shukla | CEO | Buy | 1,172 | $2.22 | $2,601.84 | 58,378 | |
| 4/4/2024 | Rajiv Shukla | CEO | Buy | 8,680 | $2.88 | $24,998.40 | 57,206 | |
| 12/14/2023 | Gilles Spenlehauer | Director | Buy | 313 | $3.61 | $1,129.93 | 4,790 | |
| 12/12/2023 | Richard A Upton | Director | Buy | 2,000 | $3.50 | $7,000.00 | 2,000 | |
| 12/7/2023 | Scott M Frisch | Director | Buy | 199 | $3.07 | $610.93 | 1,833 | |
| 12/5/2023 | Scott M Frisch | Director | Buy | 277 | $3.10 | $858.70 | 1,147 | |
| 11/30/2023 | Rajiv Shukla | CEO | Buy | 5,600 | $2.66 | $14,896.00 | 33,677 | |
| 11/28/2023 | Bryan J Cassaday | CFO | Buy | 1,500 | $2.85 | $4,275.00 | 1,500 | |
| 11/27/2023 | Rajiv Shukla | CEO | Buy | 2,100 | $2.97 | $6,237.00 | 20,562 | |
| 11/24/2023 | Rajiv Shukla | CEO | Buy | 2,715 | $2.95 | $8,009.25 | 18,462 | |
| 11/22/2023 | Rajiv Shukla | CEO | Buy | 1,185 | $2.78 | $3,294.30 | 15,747 | |
| 11/20/2023 | Rajiv Shukla | CEO | Buy | 3,750 | $2.62 | $9,825.00 | 14,362 | |
| 11/17/2023 | Rajiv Shukla | CEO | Buy | 2,000 | $2.69 | $5,380.00 | 10,612 | |
| 8/28/2023 | Rajiv Shukla | Chairman | Buy | 2,100 | $3.50 | $7,350.00 | 8,612 | |
| 8/28/2023 | Randolph W Hubbell | CEO | Buy | 100 | $3.49 | $349.00 | 2,750 | |
| 8/25/2023 | Randolph W Hubbell | CEO | Buy | 200 | $3.50 | $700.00 | 2,650 | |
| 8/24/2023 | Rajiv Shukla | Chairman | Buy | 500 | $3.50 | $1,750.00 | 5,912 | |
| 8/23/2023 | Randolph W Hubbell | CEO | Buy | 200 | $3.60 | $720.00 | 2,250 | |
| 8/21/2023 | Rajiv Shukla | Chairman | Buy | 100 | $3.54 | $354.00 | 5,412 | |
| 8/21/2023 | Randolph W Hubbell | CEO | Buy | 300 | $3.67 | $1,101.00 | 1,950 | |
| 8/18/2023 | Rajiv Shukla | Chairman | Buy | 4,100 | $3.62 | $14,842.00 | 5,312 | |
| 8/17/2023 | Randolph W Hubbell | CEO | Buy | 450 | $3.72 | $1,674.00 | 450 | |
| 8/16/2023 | Rajiv Shukla | Chairman | Buy | 1,112 | $3.74 | $4,158.88 | 1,112 | |
Carmell Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/17/2025 | Citadel Advisors LLC | 187,565 | $54K | 0.0% | N/A | 0.897% |  |
| 2/14/2025 | Antara Capital LP | 100,000 | $28K | 0.0% | N/A | 0.478% | |
| 8/9/2024 | Warberg Asset Management LLC | 45,000 | $60K | 0.0% | N/A | 0.216% | |
| 4/18/2024 | Hubbell Strickland Wealth Management LLC | 12,548 | $32K | 0.0% | N/A | 0.065% | |
| 11/15/2023 | Linden Advisors LP | 75,000 | $0.27M | 0.0% | N/A | 0.390% | |
| 11/14/2023 | Meteora Capital LLC | 1,780,919 | $6.42M | 1.1% | N/A | 9.256% | |
| 11/7/2023 | Cookson Peirce & Co. Inc. | 15,000 | $54K | 0.0% | N/A | 0.078% | |
| 11/1/2023 | Carnegie Mellon University | 103,061 | $0.37M | 0.5% | N/A | 0.536% | |
Data available starting January 2016
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
Read More on Carmell
Volume
653 shs
Average Volume
4,647,079 shs
Market Capitalization
$11.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.51
Who are the company insiders with the largest holdings of Carmell?
